NTRA Natera, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 7, 2026
$410,35
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$160,59rendah 52m
$427,47tinggi 52m
Kapitalisasi Pasar (MRQ)
$58.93B
P/E (TTM)
-304.0
EPS (TTM)
$-1.35
Pendapatan (TTM)
$2.71B
lencana Anda
Rentang 52M
$161–$427
Peringkat Analis
BUY
Target Harga
$353
P/E
-304.0
ROE
-12.5%
Margin Laba Bersih
-7.1%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
NTRA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$410.35
Kapitalisasi Pasar (MRQ)
$58.93B
P/E (TTM)
-304.0
EPS (TTM)
$-1.35
Pendapatan (TTM)
$2.71B
ROE (TTM)
-12.5%
D/E Utang/Ekuitas (MRQ)
0.0
Rentang 52M
$161–$427
NTRA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Tentang Natera, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealthcare
industriBiotechnology
karyawan6.135
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$2.31B2016-12-31 → 2025-12-31
EPS$-1.522016-12-31 → 2025-12-31
Arus Kas Bebas$109M2016-12-31 → 2025-12-31
Margin bersih-7.1%2016-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | NTRA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -304.0rata-rata 5T ≈-59.2 | ≈-59.2 | · | · | |
| P/S (TTM) | 21.8rata-rata 5T ≈10.6 | ≈10.6 | 7.3 | Terlalu mahal | |
| P/B (MRQ) | 32.4rata-rata 5T ≈13.2 | ≈13.2 | 6.2 | Terlalu mahal | |
| Harga / FCF (TTM) | 699.9rata-rata 5T ≈107.5 | ≈107.5 | · | · | |
| Harga / Arus Kas (TTM) | 258.2rata-rata 5T ≈47.2 | ≈47.2 | 18.3 | Terlalu mahal | |
| Harga / Nilai Buku Berwujud (MRQ) | 40.3rata-rata 5T ≈14.8 | ≈14.8 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | NTRA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -10.7%rata-rata 5T ≈-41.7% | ≈-41.7% | 24.0% | Lemah | |
| Margin EBITDA (TTM) | -8.8%rata-rata 5T ≈-39.8% | ≈-39.8% | 17.9% | Lemah | |
| Margin Sebelum Pajak (TTM) | -9.3%rata-rata 5T ≈-41.0% | ≈-41.0% | 13.8% | Lemah | |
| Margin Laba Bersih (TTM) | -7.1%rata-rata 5T ≈-40.5% | ≈-40.5% | 12.7% | Lemah | |
| ROA (TTM) | -8.7%rata-rata 5T ≈-27.7% | ≈-27.7% | 11.5% | Lemah | |
| ROE (TTM) | -12.5%rata-rata 5T ≈-51.6% | ≈-51.6% | 18.7% | Lemah | |
| ROIC | -13.4%rata-rata 5T ≈-43.9% | ≈-43.9% | 17.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | NTRA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.0rata-rata 5T ≈0.1 | ≈0.1 | 0.1 | Utang rendah | |
| Rasio Lancar (MRQ) | 3.0rata-rata 5T ≈4.1 | ≈4.1 | 3.2 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 0.7rata-rata 5T ≈2.3 | ≈2.3 | 2.5 | Likuiditas rendah | |
| Interest Coverage (Cakupan Bunga) | -76.2rata-rata 5T ≈-49.3 | ≈-49.3 | 8.1 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | NTRA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 35.9%rata-rata 5T ≈43.1% | ≈43.1% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 41.1%rata-rata 5T ≈40.3% | ≈40.3% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 42.6% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | NTRA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 1.1rata-rata 5T ≈0.8 | ≈0.8 | 0.5 | Tingkat teratas | |
| Receivables Turnover (Perputaran Piutang) | 7.6rata-rata 5T ≈5.6 | ≈5.6 | 6.4 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$375.9K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
17.2%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 5, 2026 | $-0.47 | $-0.50 | 6.7% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.60 | $-0.55 | -9.7% |
| 31 Des. 2025 | $0.36 | $-0.52 | 169.1% | |
| 30 Sep. 2025 | $-0.64 | $-0.38 | -68.2% | |
| 30 Juni 2025 | $-0.74 | $-0.63 | -17.8% | |
| 31 Maret 2025 | $-0.50 | $-0.65 | 23.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.26 | $9.01 | $6.40 | $6.34 | $6.87 | $5.64 | $3.57 | $0.52 | $-0.19 | $2.02 | $3.67 | · | |
| Revenue / Share | $16.87 | $13.61 | $9.41 | $8.33 | $6.91 | · | $4.35 | $4.45 | $3.94 | · | · | · | |
| Cash Flow / Share | $1.57 | $1.09 | $-2.15 | $-4.38 | $-3.70 | · | $-0.91 | $-1.22 | $-1.81 | · | · | · | |
| Cash / Share | · | · | · | $4.19 | $0.89 | $0.56 | $0.79 | $0.75 | $0.23 | $0.29 | $0.57 | · | |
| EPS (TTM) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.68 | $12.43 | · | $9.10 | $9.11 | $9.12 | · | $7.08 | $6.78 | $6.50 | · | $6.59 | $5.23 | $5.74 | · | $3.72 | |
| Revenue / Share | $5.25 | $4.92 | · | $4.32 | $4.01 | $3.72 | · | $3.55 | $3.36 | $3.04 | · | $2.33 | $2.30 | $2.16 | · | $2.17 | |
| Cash Flow / Share | · | $0.28 | · | · | · | $0.33 | · | · | · | $0.22 | · | · | · | $-0.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.59 | |
| EPS (TTM) | $-1.35 | $-1.62 | · | $-2.29 | $-1.91 | $-1.47 | · | $-1.75 | $-2.44 | $-3.11 | · | $-4.52 | $-4.82 | $-5.35 | · | $-5.72 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.71B | $2.50B | · | $2.12B | $1.96B | $1.83B | · | $1.53B | $1.36B | $1.21B | · | $989M | $931M | $868M | · | $776M | |
| Net Income TTM | $-192M | $-226M | · | $-309M | $-253M | $-190M | · | $-215M | $-292M | $-365M | · | $-499M | $-512M | $-546M | · | $-546M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -201.1 | -123.5 | · | -70.3 | -88.5 | -96.2 | · | -72.5 | -44.4 | -29.4 | · | -9.8 | -10.1 | -10.4 | · | -7.7 | |
| P/S | 14.4 | 11.4 | · | 10.5 | 11.8 | 10.5 | · | 10.3 | 9.8 | 9.3 | · | 5.3 | 6.0 | 7.3 | · | 5.5 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 4.9 | |
| Earnings Yield | -0.50% | -0.81% | · | -1.4% | -1.1% | -1.0% | · | -1.4% | -2.2% | -3.4% | · | -10.2% | -9.9% | -9.6% | · | -13.1% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $2.31B | $1.70B | $1.08B | $820M | $625M |
| Margin Operasi % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| Laba Bersih | $-208M | $-190M | $-435M | $-548M | $-472M |
| EPS Dilusian | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Rasio Lancar | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| Rasio Cepat | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $109M | $69M | $-286M | $-479M | $-376M |
Pemilik institusional (13F) 928 pengaju · $36.5B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
928
Nilai yang dipegang
$36.5B
Posisi baru
166
Posisi yang keluar
63
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 166 (+55 vs Kuartal sebelumnya) | 63 (-37 vs Kuartal sebelumnya) | 359 (+56 vs Kuartal sebelumnya) | 247 (-14 vs Kuartal sebelumnya) | +8.7M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | $3.505.094.525 | 12.865.346 | 9,61% | Saham |
| BlackRock, Inc. | $2.962.770.331 | 10.914.608 | 8,12% | Saham |
| VANGUARD GROUP INC | $2.819.278.675 | 12.306.424 | 7,73% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.690.649.234 | 6.228.216 | 4,63% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.569.697.628 | 5.782.640 | 4,30% | Saham |
| FMR LLC | $1.479.781.281 | 5.451.396 | 4,06% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.096.858.330 | 4.040.738 | 3,01% | Saham |
| STATE STREET CORP | $992.317.506 | 3.655.618 | 2,72% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $744.565.293 | 2.750.013 | 2,04% | Saham |
| FRANKLIN RESOURCES INC | $739.946.472 | 2.725.903 | 2,03% | Saham |
| Castle Hook Partners LP | $704.759.120 | 2.596.276 | 1,93% | Saham |
| COATUE MANAGEMENT LLC | $680.006.681 | 2.505.090 | 1,86% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $628.086.698 | 2.344.570 | 1,72% | Saham |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602.175.451 | 2.218.366 | 1,65% | Saham |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $535.084.922 | 1.971.391 | 1,47% | Saham |
| NORGES BANK | $496.243.717 | 1.828.122 | 1,36% | Saham |
| FRED ALGER MANAGEMENT, LLC | $482.640.543 | 1.778.009 | 1,32% | Saham |
| GOLDMAN SACHS GROUP INC | $466.935.338 | 1.720.152 | 1,28% | Saham |
| Sofinnova Investments, Inc. | $420.823.506 | 1.550.280 | 1,15% | Saham |
| Capital World Investors | $408.365.851 | 1.504.387 | 1,12% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408.180.994 | 1.503.706 | 1,12% | Saham |
| MAVERICK CAPITAL LTD | $368.266.171 | 1.356.663 | 1,01% | Saham |
| D. E. Shaw & Co., Inc. | $347.253.770 | 1.279.255 | 0,95% | Saham |
| MORGAN STANLEY | $345.906.057 | 1.274.287 | 0,95% | Saham |
| FEDERATED HERMES, INC. | $309.172.863 | 1.138.968 | 0,85% | Saham |
| Clearbridge Investments, LLC | $276.424.438 | 1.018.325 | 0,76% | Saham |
| RTW INVESTMENTS, LP | $271.450.000 | 1.000.000 | 0,74% | Saham |
| JANE STREET GROUP, LLC | $251.630.350 | 926.986 | 0,69% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $249.356.413 | 918.609 | 0,68% | Saham |
| Invesco Ltd. | $237.065.949 | 873.332 | 0,65% | Saham |
| NORTHERN TRUST CORP | $227.070.096 | 836.508 | 0,62% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $218.934.197 | 806.536 | 0,60% | Saham |
| BANK OF AMERICA CORP /DE/ | $199.960.146 | 736.637 | 0,55% | Saham |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197.243.187 | 726.628 | 0,54% | Saham |
| ARK Investment Management LLC | $186.989.592 | 688.855 | 0,51% | Saham |
| Sumitomo Mitsui Trust Group, Inc. | $174.716.892 | 643.643 | 0,48% | Saham |
| Chevy Chase Trust Holdings, LLC | $162.830.912 | 599.856 | 0,45% | Saham |
| RAYMOND JAMES FINANCIAL INC | $160.992.382 | 593.083 | 0,44% | Saham |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160.551.817 | 591.460 | 0,44% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $150.579.670 | 752.936 | 0,41% | Saham |
| UBS Group AG | $150.312.452 | 553.739 | 0,41% | Saham |
| Legal & General Group Plc | $150.142.799 | 553.114 | 0,41% | Saham |
| Bank of New York Mellon Corp | $149.277.609 | 549.927 | 0,41% | Saham |
| FIRST TRUST ADVISORS LP | $138.768.953 | 511.214 | 0,38% | Saham |
| WELLS FARGO & COMPANY/MN | $136.489.991 | 502.818 | 0,37% | Saham |
| Nuveen, LLC | $135.477.536 | 499.089 | 0,37% | Saham |
| GILDER GAGNON HOWE & CO LLC | $135.199.396 | 498.064 | 0,37% | Saham |
| AMERICAN CENTURY COMPANIES INC | $129.951.802 | 478.732 | 0,36% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $125.949.543 | 463.988 | 0,35% | Saham |
| Avala Global LP | $124.867.000 | 460.000 | 0,34% | Saham |
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 pengajuan | 13 Feb. 2020 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 21 orang dalam · 7 pejabat · 15 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Steven Leonard Chapman | CEO AND PRESIDENT | 1 Okt. 2026 S | 96.926 | 0 | 54 | $-90.749.334 |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 4 Agu 2026 S | 51.637 | 0 | 41 | $-21.731.496 |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1 Okt. 2026 S | 106.914 | 0 | 64 | $-23.640.470 |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 10 Agu 2026 S | 197.257 | 0 | 18 | $-9.345.666 |
| Robert Alan Schueren | CHIEF OPERATING OFFICER | 27 Jan. 2023 A | 24.091 | 0 | 0 | $0 |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 15 Sep. 2026 S | 0 | 0 | 92 | $-124.045.289 |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 3 Agu 2026 S | 170.073 | 0 | 41 | $-23.609.158 |
| Jonathan Sheena | Direktur | 23 Sep. 2026 S | 9.000 | 0 | 144 | $-29.839.868 |
| Rowan E Chapman | Direktur | 15 Juli 2026 S | 4.663 | 0 | 5 | $-1.764.386 |
| Eric H Rubin | Direktur | 26 Juni 2026 A | 2.204 | 0 | 0 | $0 |
| Monica Bertagnolli | Direktur | 26 Juni 2026 A | 7.020 | 0 | 0 | $0 |
| Gail Boxer Marcus | Direktur | 26 Juni 2026 A | 7.852 | 0 | 5 | $-2.413.550 |
| Roy D. Baynes | Direktur | 26 Juni 2026 A | 20.158 | 0 | 8 | $-2.809.687 |
| Thomas J. Lynch Jr. | Direktur | 26 Juni 2026 A | 1.905 | 0 | 0 | $0 |
| Herm Rosenman | Direktur | 26 Juni 2026 A | 5.927 | 0 | 5 | $-15.143.996 |
| ROELOF BOTHA ("RB") | Direktur | 26 Juni 2026 A | 4.585 | 0 | 17 | $-34.892.929 |
| Dr. James I. Healy | Direktur | 25 April 2025 A | 46.260 | 0 | 0 | $0 |
| Todd C Cozzens | Direktur | 25 Mei 2022 M | 15.813 | 0 | 0 | $0 |
| John Steuart | Direktur | 16 Mei 2019 M | 7.278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | Direktur | 16 Mei 2019 M | 52.009 | 0 | 0 | $0 |
| Ruth Williams Brinkley | · | 24 April 2026 A | 5.475 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 73 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 6,23% | 63.892 SH | 1 Okt. 2026 | Harian |
| ARKG · ARK ETF Trust | 4,13% | 240.145 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 3,30% | 1.043.662 SH | 11 Sep. 2026 | Harian |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 3,01% | 85.121 SH | 1 Okt. 2026 | Harian |
| MEDI · Harbor ETF Trust | 2,26% | 3.475 NS | 31 Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,23% | 87.424 NS | 31 Juli 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,23% | 5.764 NS | 31 Juli 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,74% | 13.080 NS | 31 Juli 2026 | N-PORT |
| GURU · Global X Funds | 1,52% | 3.466 NS | 31 Juli 2026 | N-PORT |
| IWP · iShares Trust | 1,31% | 769.818 SH | 11 Sep. 2026 | Harian |
| ARKK · ARK ETF Trust | 1,24% | 257.162 NS | 31 Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1.802.288 SH | 19 Agu 2026 | Harian |
| HQGO · Lattice Strategies Trust | 0,86% | 1.588 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,84% | 15.588 NS | 31 Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,80% | 460 NS | 31 Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,79% | 59.919 NS | 31 Juli 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,77% | 37.874 NS | 31 Juli 2026 | N-PORT |
| TEXN · iShares Trust | 0,74% | 426 SH | 11 Sep. 2026 | Harian |
| IYH · iShares Trust | 0,72% | 79.898 SH | 11 Sep. 2026 | Harian |
| IMCG · iShares Trust | 0,62% | 75.541 SH | 11 Sep. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,54% | 404.713 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,52% | 64.051 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1.643.356 SH | 19 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3.120.454 SH | 19 Agu 2026 | Harian |
| LQAI · Exchange Listed Funds Trust | 0,41% | 34 NS | 31 Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,38% | 8.233 NS | 31 Juli 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,36% | 20.763 NS | 31 Juli 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,35% | 9.234 NS | 31 Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,33% | 559.634 SH | 11 Sep. 2026 | Harian |
| SIZE · iShares Trust | 0,32% | 4.182 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,32% | 20.796 SH | 1 Okt. 2026 | Harian |
| IMCB · iShares Trust | 0,31% | 15.983 SH | 11 Sep. 2026 | Harian |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 27.638 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,24% | 213 NS | 31 Juli 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,20% | 12.005 SH | 11 Sep. 2026 | Harian |
| ILCG · iShares Trust | 0,14% | 13.232 SH | 11 Sep. 2026 | Harian |
| IWF · iShares Trust | 0,14% | 513.245 SH | 11 Sep. 2026 | Harian |
| VEGN · ETF Series Solutions | 0,12% | 801 NS | 31 Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 2.314 SH | 1 Okt. 2026 | Harian |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 132 NS | 31 Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 216.186 SH | 19 Agu 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 7.532 SH | 19 Agu 2026 | Harian |
| HAPI · Harbor ETF Trust | 0,10% | 1.778 NS | 31 Juli 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,09% | 23.494 SH | 1 Okt. 2026 | Harian |
| USCL · iShares Trust | 0,08% | 7.220 SH | 11 Sep. 2026 | Harian |
| GARP · iShares Trust | 0,07% | 7.023 SH | 11 Sep. 2026 | Harian |
| ILCB · iShares Trust | 0,07% | 2.633 SH | 11 Sep. 2026 | Harian |
| IYY · iShares Trust | 0,07% | 6.130 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,06% | 187.328 SH | 11 Sep. 2026 | Harian |
| IWB · iShares Trust | 0,06% | 95.076 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,06% | 37.512 SH | 11 Sep. 2026 | Harian |
| ESGV · VANGUARD WORLD FUND | 0,06% | 30.869 SH | 19 Agu 2026 | Harian |
| BKLC · BNY Mellon ETF Trust | 0,06% | 11.523 NS | 31 Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,06% | 2.309 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,05% | 42.084 NS | 31 Juli 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,05% | 11.689 NS | 31 Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 379 SH | 11 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,05% | 4.321.128 SH | 19 Agu 2026 | Harian |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,05% | 22.505 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,05% | 11.503 SH | 19 Agu 2026 | Harian |
| TOV · EA Series Trust | 0,05% | 479 NS | 31 Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 11.995 SH | 11 Sep. 2026 | Harian |
| CRBN · iShares Trust | 0,05% | 1.666 SH | 11 Sep. 2026 | Harian |
| ACWI · iShares Trust | 0,04% | 42.227 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,04% | 3.402 NS | 31 Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 3.537 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 18.510 NS | 31 Juli 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 113.866 SH | 19 Agu 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,03% | 3.396 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 42.957 NS | 31 Juli 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,02% | 132 NS | 31 Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.514 SH | 1 Okt. 2026 | Harian |
| SMLF · iShares Trust | · | 96.755 SH | 11 Sep. 2026 | Harian |
NTRA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 30 analis
BELI
Target median
$360.00
-12,3%
12 40,0%
Beli Kuat
14 46,7%
Beli
4 13,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
23 analis · 2026-09-28Target rata-rata $352.80 -14,0%
Sekarang
Harga saat ini $410.35
Rendah$280.00
Rata-rata$352.80
Tinggi$460.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | · |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | · |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | · |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | · |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | · |
| RVMD | · | · | · | · | · | · |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | · |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | · |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | · |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Natera Inc. (NTRA): Pilihan Saham Milliardai Tom Steyer dengan Potensi Naik Besar
Yahoo Finance · 4 bulan, 4 minggu lalu
Stanley Druckenmiller Membuat 1 Taruhan Besar yang Masih Terlihat Menarik Hari Ini dan Memangkas 2 Posisi Teratas
Yahoo Finance · 5 bulan, 2 minggu lalu
Natera Inc. (NTRA): Potensi Kenaikan Harga Menarik Perhatian Miliarder Stan Druckenmiller
Yahoo Finance · 5 bulan, 3 minggu lalu
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 7, 2026